-
FDA approves new indication for Genentech’s Lucentis
SILVER SPRING, Md. — The Food and Drug Administration has approved a new indication for Genentech’s Lucentis (ranibizumab injection). The drug has been approved to treat patients with myopic choroidal neovascularization, which is a complication of severe near-sightedness that can lead to blindness.National Association of Specialty Pharmacy names new president and president-elect
WASHINGTON, D.C. — The National Association of Specialty Pharmacy named Rebecca Shanahan president and Mike Agostino president-elect effective Jan. 1.
Each served on the non-profit organization’s board of directors and executive committee. Shanahan, a 20-plus year industry veteran and CEO of Avella Specialty Pharmacy, is succeeding Burt Zweigenhaft in the role.